Skip to main content

Proposed bulletins

Public comments

The bulletins below are in the process of development by the Division of Financial Regulation (DFR). The division is asking for public review and comment as part of that process. All comments received will be given full consideration and a final report discussing our general response as applied to the bulletin’s final version will be released.

Submit comments

Comments can be submitted in the following ways (Please include the bulletin number or name in the subject line of your comment):

Email:
dfr.bulletin@oregon.gov

Mail:
Department of Consumer and Business Services
Division of Financial Regulation
350 Winter St. NE
P.O. Box 14480
Salem, OR 97309-0405

Proposed bulletins

Click titles for details and documents.
Most current on top.

Audience: All manufacturers of prescription drugs sold in Oregon

Purpose:
This bulletin clarifies the definition of “new prescription drug” in OAR 836-200-0505, regarding whether a report is required under OAR 836-200-0520 and ORS 646A.689. The term “original new drug application,” for “specialty drug” reports required under ORS 646A.689, includes both novel drugs and acquired drugs previously approved.

The definition of “new prescription drug” for reporting under the Oregon Drug Price Transparency Act

Public comments requested: Please send public comments to DFR.Bulletin@oregon.gov.

Last day for public comment: Friday, February 26, 2021, 5 p.m.


Summary:
Exclusionary language relating to controlled substances must clearly describe the risks being excluded. Policies containing exclusions for controlled substances must clarify that the legitimate use of prescription drugs is not excluded. Exclusions relating to the use or other activity associated with controlled substances must be limited to losses that are causally related to the described activity. The division requests feedback from all stakeholders on the attached guidance. This is a request for a 2nd round of public comment. Please submit all comments to DFR.Bulletin@oregon.gov.

Draft Bulletin: Guidance on Exclusionary Language Regarding Controlled Substances

Last day for public comment: Friday, November 13, 2020


Summary:
Recently, DFR has received numerous policy filings applying new, expansive language to intentional acts of exclusions. Intentional acts exclusions may not encompass losses due to negligence. Policy language must apply intentional acts exclusions to “the insured.” The division requests feedback from all stakeholders on the attached guidance. Please submit all comments to Raven.V.Collins@oregon.gov.

Draft Bulletin: Guidance on Intentional Acts Exclusions

Last day for public comment: Monday, February 10, 2020



Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how

×